Drugs / AQUA07
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07617337 | Jul 2026 → Aug 2030 expected | non-small cell lung carcinoma | Chugai Pharmaceutical | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AQUA07 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07617337 ↗ |
| Route | Oral | “AQUA07 administrated orally” NCT07617337 ↗ |